Acta Med. 2008, 51: 95-99
https://doi.org/10.14712/18059694.2017.9
The Influence of Cisplatin Dose upon Survival in Concurrent Chemoradiotherapy of Locally Advanced Cervical Carcinoma with Weekly Cisplatin
References
1. DR. Regression model and life tables. J Royal Stat Soc 1972; series B34:187–220.
2. PJ. Chemoradiotherapy in the treatment of cervical cancer. Semin Radiat Oncol 2006; 16:177–85.
<https://doi.org/10.1016/j.semradonc.2006.02.007>
3. T, Rey A, Roche B, et al. Overall treatment time in advanced cervical carcinomas: a critical parameter in treatment outcome. Int J Radiat Oncol Biol Phys 1993; 27:1051–6.
<https://doi.org/10.1016/0360-3016(93)90522-W>
4. JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001; 358:781–6.
<https://doi.org/10.1016/S0140-6736(01)05965-7>
5. FL, Meier P. Non parametric estimation from incomplete observations. Am J Stat Assoc 1958; 53:457–481.
<https://doi.org/10.1080/01621459.1958.10501452>
6. JM, Symonds P, Green JA, Tierney J, Collingwood M, Williams CJ. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiotherap and Oncol 2003; 68:217–26.
<https://doi.org/10.1016/S0167-8140(03)00197-X>
7. MR, Pajak TF, Martz K, Hanks GE. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a Patterns-of-Care study. Int J Radiat Oncol Biol Phys 1993; 25:391–7.
<https://doi.org/10.1016/0360-3016(93)90058-4>
8. H, Hirte H, Fyles A, et al. Concurrent Cisplatin-based Chemotherapy plus Radiotherapy for Cervical Cancer – a Meta-analysis. Clinical Oncology 2002; 14:203–12.
<https://doi.org/10.1053/clon.2002.0076>
9. M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high risk cervical cancer. N Engl J Med 1999; 340:1137–43.
<https://doi.org/10.1056/NEJM199904153401501>
10. TK, Kim SN, Kim SW, Kim GE, Suh CO. Concurrent chemotherapy and radiotherapy in invasive cervical cancer patients with high risk factors. J Korean Med Sci 2000; 15:436–41.
<https://doi.org/10.3346/jkms.2000.15.4.436>
<PubMed>
11. R, Brundage M, Drouin P, et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol 2002; 20:966–72.
<https://doi.org/10.1200/JCO.2002.20.4.966>
12. CA, Grigsby PW, Castro Vita H, Lockett MA. Carcinoma of the uterine cervix. I. Impact of prolongation of treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1995; 32:1275–88.
<https://doi.org/10.1016/0360-3016(95)00220-S>
13. R, Peto J. Asymptomatically efficient rank invariant prosedures. J Royal Stat Soc 1972; 135:185–207.
<https://doi.org/10.2307/2344317>
14. PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999; 340:1144–53.
<https://doi.org/10.1056/NEJM199904153401502>
15. K, Jassem J. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity. Int J Radiat Oncol Biol Phys 2004; 60:814–21.
<https://doi.org/10.1016/j.ijrobp.2004.04.042>
16. JM, Stehman FB. Concurrent chemotherapy and radiation therapy in primary cancer of the cervix. Curr Oncol Rep 1999; 1:41–6.
<https://doi.org/10.1007/s11912-999-0008-4>
17. HG, Kuhnt T, Laban C, et al. Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Strahlenther Onkol 2002; 178:378–85.
<https://doi.org/10.1007/s00066-002-0956-1>
18. GM. Concurrent chemotherapy and radiation for locally advanced cervical cancer: the new standard of care. Semin Radiat Oncol 2000; 10: 44–50.
<https://doi.org/10.1016/S1053-4296(00)80020-X>
19. T, Moromizato H, Ogawa K, et al. Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer. Gynecol Oncology 2005; 96:665–70.
<https://doi.org/10.1016/j.ygyno.2004.11.046>
20. CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative paraaortic lymph-nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1997; 17:1339–48.
<https://doi.org/10.1200/JCO.1999.17.5.1339>
